What is International Stem Cell Revenue per Share?
International Stem Cell's revenue per share for the
three
months ended in Mar. 2024 was $0.27.
International Stem Cell's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.98.
Warning Sign:
International Stem Cell Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of International Stem Cell was -5.00% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 1.00% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -9.70% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was -19.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for International Stem Cell's Revenue per Share or its related term are showing as below:
ISCO'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -33.1 Med: -14.7 Max: 475.8
Current: 1
During the past 13 years, International Stem Cell's highest 3-Year average Revenue Per Share Growth Rate was 475.80% per year. The lowest was -33.10% per year. And the median was -14.70% per year.
ISCO's 3-Year Revenue Growth Rate is ranked worse than 54.94% of 779
companies
in the Biotechnology industry
Industry Median: 3.7
vs ISCO: 1.00
International Stem Cell Revenue per Share Historical Data
The historical data trend for International Stem Cell's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of International Stem Cell's Revenue per Share
For the Biotechnology subindustry, International Stem Cell's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Stem Cell's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Stem Cell's PS Ratio distribution charts can be found below:
* The bar in red indicates where International Stem Cell's PS Ratio falls into.
International Stem Cell Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
International Stem Cell's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.98
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Stem Cell (OTCPK:ISCO) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
International Stem Cell Revenue per Share Related Terms
Thank you for viewing the detailed overview of International Stem Cell's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
International Stem Cell (International Stem Cell) Business Description
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISCO has been successfully added to your 